Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


The ESMO Sarcoma & GIST 2022 virtual programme is online!

Access the online programme

Preceptorship Course  

Half a day meeting designed to provide oncologists with a brief outline of both STS & GIST. The course aims to be the contact or re-introduction with these diseases for oncologists who are interested to know more about them and to have an introduction to the high-profile Symposium in the two days afterwards.

Advanced Course 

Half a day meeting offering an intensive discussion of a set of clinical cases of paediatric, adolescent and young adult STS & GIST for professionals who are already familiar with these diseases. Attendees will benefit from discussions about challenging clinical cases with specialists from both the EU and USA, leveraging the different perspectives and expertise across continents.

Main Symposium

The goal is to merge the clinical and the translational perspectives into a single high-profile educational event.  The Symposium is known as an excellent place for international networking and collaboration, featuring discussions with the key opinion leaders in the field.  A world-renowned faculty will attract an audience of experts in sarcomas, highlighting breakthroughs in state of the art management strategies, novel therapeutic discoveries and clinical research perspectives.

Learning objectives

  • Understand the complex molecular biology and histopathological classification of sarcomas and GIST
  • Understand the principles of locoregional management of patients with soft tissue and bone sarcomas
  • Be informed on state of the art and emerging systemic therapies of soft tissue and bone sarcomas
  • Receive an update on standard multidisciplinary treatment of patients with localized and metastatic gist
  • Gain insights on novel targeted therapies, immunotherapies and cell-based therapies of sarcoma
  • Receive updates on trends in clinical research design and methodology in the sarcoma field


ESMO-MORA: The ESMO Sarcoma & GIST 2022 virtual programme has been accredited with 10 Cat.1 ESMO MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.


The Symposia webcasts will be available for all delegates and will include all the sessions of the official programme where speaker permission is granted. ESMO Members who do not register for the Symposia will have access to the resources 2 months after the end of the meeting.


All Speakers are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).

The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.